Viridian Therapeutics Inc
(NASDAQ:VRDN)
$14.60
0[0.00%]
Last update: 4:20PM (Delayed 15-Minutes)
Get Real Time Here
$14.60
0[0.00%]
Open-Close-
Vol / Avg.0 / 687.384KMkt Cap637.584M
Day Range- - -52 Wk Range14.400 - 39.000

Viridian Therapeutics Stock (NASDAQ:VRDN) Earnings Dates and Earning Calls

Viridian Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Nov 13

EPS Estimate

$-1.240

Quarterly Revenue Estimate

$110K

Annual Revenue (as of Jun 30)

$1.5M

Earnings History

Analyze the earnings history of Viridian Therapeutics using advanced sorting and filters.

Q

When is Viridian Therapeutics (NASDAQ:VRDN) reporting earnings?

A

Viridian Therapeutics (VRDN) is scheduled to report earnings on November 13, 2023. The last reported earnings were for reported on August 8, 2023 for Q2.

Q

What were the latest earnings per share (EPS) for Viridian Therapeutics (NASDAQ:VRDN)?

A

The Actual EPS was $-1.27, which beat the estimate of $-1.29.

Q

What were Viridian Therapeutics’s (NASDAQ:VRDN) revenues?

A

The Actual Revenue was $72K, which missed the estimate of $220K.

Browse earnings estimates, EPS, and revenue on all stocks.

Viridian Therapeutics Stock (NASDAQ:VRDN) Earnings Dates and Earning Calls

Viridian Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Nov 13

EPS Estimate

$-1.240

Quarterly Revenue Estimate

$110K

Annual Revenue (as of Jun 30)

$1.5M

Earnings History

Analyze the earnings history of Viridian Therapeutics using advanced sorting and filters.

Q

When is Viridian Therapeutics (NASDAQ:VRDN) reporting earnings?

A

Viridian Therapeutics (VRDN) is scheduled to report earnings on November 13, 2023. The last reported earnings were for reported on August 8, 2023 for Q2.

Q

What were the latest earnings per share (EPS) for Viridian Therapeutics (NASDAQ:VRDN)?

A

The Actual EPS was $-1.27, which beat the estimate of $-1.29.

Q

What were Viridian Therapeutics’s (NASDAQ:VRDN) revenues?

A

The Actual Revenue was $72K, which missed the estimate of $220K.

Browse earnings estimates, EPS, and revenue on all stocks.

Viridian Therapeutics Stock (NASDAQ:VRDN) Earnings Dates and Earning Calls

Viridian Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Nov 13

EPS Estimate

$-1.240

Quarterly Revenue Estimate

$110K

Annual Revenue (as of Jun 30)

$1.5M

Earnings History

Analyze the earnings history of Viridian Therapeutics using advanced sorting and filters.

Q

When is Viridian Therapeutics (NASDAQ:VRDN) reporting earnings?

A

Viridian Therapeutics (VRDN) is scheduled to report earnings on November 13, 2023. The last reported earnings were for reported on August 8, 2023 for Q2.

Q

What were the latest earnings per share (EPS) for Viridian Therapeutics (NASDAQ:VRDN)?

A

The Actual EPS was $-1.27, which beat the estimate of $-1.29.

Q

What were Viridian Therapeutics’s (NASDAQ:VRDN) revenues?

A

The Actual Revenue was $72K, which missed the estimate of $220K.

Browse earnings estimates, EPS, and revenue on all stocks.

Viridian Therapeutics Stock (NASDAQ:VRDN) Earnings Dates and Earning Calls

Viridian Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Nov 13

EPS Estimate

$-1.240

Quarterly Revenue Estimate

$110K

Annual Revenue (as of Jun 30)

$1.5M

Earnings History

Analyze the earnings history of Viridian Therapeutics using advanced sorting and filters.

Q

When is Viridian Therapeutics (NASDAQ:VRDN) reporting earnings?

A

Viridian Therapeutics (VRDN) is scheduled to report earnings on November 13, 2023. The last reported earnings were for reported on August 8, 2023 for Q2.

Q

What were the latest earnings per share (EPS) for Viridian Therapeutics (NASDAQ:VRDN)?

A

The Actual EPS was $-1.27, which beat the estimate of $-1.29.

Q

What were Viridian Therapeutics’s (NASDAQ:VRDN) revenues?

A

The Actual Revenue was $72K, which missed the estimate of $220K.

Browse earnings estimates, EPS, and revenue on all stocks.

Viridian Therapeutics Stock (NASDAQ:VRDN) Earnings Dates and Earning Calls

Viridian Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Nov 13

EPS Estimate

$-1.240

Quarterly Revenue Estimate

$110K

Annual Revenue (as of Jun 30)

$1.5M

Earnings History

Analyze the earnings history of Viridian Therapeutics using advanced sorting and filters.

Q

When is Viridian Therapeutics (NASDAQ:VRDN) reporting earnings?

A

Viridian Therapeutics (VRDN) is scheduled to report earnings on November 13, 2023. The last reported earnings were for reported on August 8, 2023 for Q2.

Q

What were the latest earnings per share (EPS) for Viridian Therapeutics (NASDAQ:VRDN)?

A

The Actual EPS was $-1.27, which beat the estimate of $-1.29.

Q

What were Viridian Therapeutics’s (NASDAQ:VRDN) revenues?

A

The Actual Revenue was $72K, which missed the estimate of $220K.

Browse earnings estimates, EPS, and revenue on all stocks.

Viridian Therapeutics Stock (NASDAQ:VRDN) Earnings Dates and Earning Calls

Viridian Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Nov 13

EPS Estimate

$-1.240

Quarterly Revenue Estimate

$110K

Annual Revenue (as of Jun 30)

$1.5M

Earnings History

Analyze the earnings history of Viridian Therapeutics using advanced sorting and filters.

Q

When is Viridian Therapeutics (NASDAQ:VRDN) reporting earnings?

A

Viridian Therapeutics (VRDN) is scheduled to report earnings on November 13, 2023. The last reported earnings were for reported on August 8, 2023 for Q2.

Q

What were the latest earnings per share (EPS) for Viridian Therapeutics (NASDAQ:VRDN)?

A

The Actual EPS was $-1.27, which beat the estimate of $-1.29.

Q

What were Viridian Therapeutics’s (NASDAQ:VRDN) revenues?

A

The Actual Revenue was $72K, which missed the estimate of $220K.

Browse earnings estimates, EPS, and revenue on all stocks.

Viridian Therapeutics Stock (NASDAQ:VRDN) Earnings Dates and Earning Calls

Viridian Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Nov 13

EPS Estimate

$-1.240

Quarterly Revenue Estimate

$110K

Annual Revenue (as of Jun 30)

$1.5M

Earnings History

Analyze the earnings history of Viridian Therapeutics using advanced sorting and filters.

Q

When is Viridian Therapeutics (NASDAQ:VRDN) reporting earnings?

A

Viridian Therapeutics (VRDN) is scheduled to report earnings on November 13, 2023. The last reported earnings were for reported on August 8, 2023 for Q2.

Q

What were the latest earnings per share (EPS) for Viridian Therapeutics (NASDAQ:VRDN)?

A

The Actual EPS was $-1.27, which beat the estimate of $-1.29.

Q

What were Viridian Therapeutics’s (NASDAQ:VRDN) revenues?

A

The Actual Revenue was $72K, which missed the estimate of $220K.

Browse earnings estimates, EPS, and revenue on all stocks.

Viridian Therapeutics Stock (NASDAQ:VRDN) Earnings Dates and Earning Calls

Viridian Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Nov 13

EPS Estimate

$-1.240

Quarterly Revenue Estimate

$110K

Annual Revenue (as of Jun 30)

$1.5M

Earnings History

Analyze the earnings history of Viridian Therapeutics using advanced sorting and filters.

Q

When is Viridian Therapeutics (NASDAQ:VRDN) reporting earnings?

A

Viridian Therapeutics (VRDN) is scheduled to report earnings on November 13, 2023. The last reported earnings were for reported on August 8, 2023 for Q2.

Q

What were the latest earnings per share (EPS) for Viridian Therapeutics (NASDAQ:VRDN)?

A

The Actual EPS was $-1.27, which beat the estimate of $-1.29.

Q

What were Viridian Therapeutics’s (NASDAQ:VRDN) revenues?

A

The Actual Revenue was $72K, which missed the estimate of $220K.

Browse earnings estimates, EPS, and revenue on all stocks.

Viridian Therapeutics Stock (NASDAQ:VRDN) Earnings Dates and Earning Calls

Viridian Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Nov 13

EPS Estimate

$-1.240

Quarterly Revenue Estimate

$110K

Annual Revenue (as of Jun 30)

$1.5M

Earnings History

Analyze the earnings history of Viridian Therapeutics using advanced sorting and filters.

Q

When is Viridian Therapeutics (NASDAQ:VRDN) reporting earnings?

A

Viridian Therapeutics (VRDN) is scheduled to report earnings on November 13, 2023. The last reported earnings were for reported on August 8, 2023 for Q2.

Q

What were the latest earnings per share (EPS) for Viridian Therapeutics (NASDAQ:VRDN)?

A

The Actual EPS was $-1.27, which beat the estimate of $-1.29.

Q

What were Viridian Therapeutics’s (NASDAQ:VRDN) revenues?

A

The Actual Revenue was $72K, which missed the estimate of $220K.

Browse earnings estimates, EPS, and revenue on all stocks.